Betta Pharmaceuticals Co., Ltd. (hereinafter referred to as "the Company") and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
Today, the Company received a notice from its shareholder, Ningbo Kaiming Investment Management Partnership (Limited Partnership) (hereinafter referred to as "Kaiming Investment"), regarding changes in the pledge of part of its shares. The specific situation is announced as follows:
I. Basic Situation of Shareholder Share Pledge
- New Pledge Situation of Kaiming Investment
| Shareholder Name | Is the Shareholder a Controlling Shareholder or the Largest Shareholder and its Concerted Parties | Number of Shares Pledged (shares) | Proportion of Pledged Shares to Holdings | Proportion of Pledged Shares to Total Share Capital | Is it a Restricted Share | Is it a Supplementary Pledge | Pledge Start Date | Pledge Expiry Date | Pledgee | Pledge Purpose |
|------------------|------------------------------------------------------------------------------------------------|-----------------------------------|-----------------------------------------------|-----------------------------------------------|---------------------|---------------------|------------------|------------------|----------------|----------------|
| Kaiming Investment | Yes | 14,680,000 | 18.34% | 3.49% | No | No | 2026-5-29 | 2027-5-27 | Hangzhou Bank Co., Ltd. Technology Branch | Self-operation |